vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Madison Square Garden Entertainment Corp. (MSGE). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $424.8M, roughly 1.1× Madison Square Garden Entertainment Corp.). Madison Square Garden Entertainment Corp. runs the higher net margin — 21.8% vs -10.1%, a 31.9% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 12.5%). Over the past eight quarters, Madison Square Garden Entertainment Corp.'s revenue compounded faster (48.9% CAGR vs 18.6%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

CLOV vs MSGE — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.1× larger
CLOV
$487.7M
$424.8M
MSGE
Growing faster (revenue YoY)
CLOV
CLOV
+32.2% gap
CLOV
44.7%
12.5%
MSGE
Higher net margin
MSGE
MSGE
31.9% more per $
MSGE
21.8%
-10.1%
CLOV
Faster 2-yr revenue CAGR
MSGE
MSGE
Annualised
MSGE
48.9%
18.6%
CLOV

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CLOV
CLOV
MSGE
MSGE
Revenue
$487.7M
$424.8M
Net Profit
$-49.3M
$92.7M
Gross Margin
Operating Margin
-10.1%
38.6%
Net Margin
-10.1%
21.8%
Revenue YoY
44.7%
12.5%
Net Profit YoY
-123.2%
22.2%
EPS (diluted)
$1.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
MSGE
MSGE
Q4 25
$487.7M
$424.8M
Q3 25
$496.6M
$154.1M
Q2 25
$477.6M
$145.1M
Q1 25
$462.3M
$206.0M
Q4 24
$337.0M
$377.6M
Q3 24
$331.0M
$134.1M
Q2 24
$356.3M
$177.6M
Q1 24
$346.9M
$191.6M
Net Profit
CLOV
CLOV
MSGE
MSGE
Q4 25
$-49.3M
$92.7M
Q3 25
$-24.4M
$-21.7M
Q2 25
$-10.6M
$-27.2M
Q1 25
$-1.3M
$8.0M
Q4 24
$-22.1M
$75.9M
Q3 24
$-9.2M
$-19.3M
Q2 24
$7.4M
$66.9M
Q1 24
$-19.2M
$2.8M
Gross Margin
CLOV
CLOV
MSGE
MSGE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
MSGE
MSGE
Q4 25
-10.1%
38.6%
Q3 25
-4.9%
-19.3%
Q2 25
-2.2%
-17.7%
Q1 25
-0.3%
13.3%
Q4 24
-6.4%
36.8%
Q3 24
-2.7%
-13.8%
Q2 24
2.0%
-5.0%
Q1 24
-6.5%
8.8%
Net Margin
CLOV
CLOV
MSGE
MSGE
Q4 25
-10.1%
21.8%
Q3 25
-4.9%
-14.0%
Q2 25
-2.2%
-18.7%
Q1 25
-0.3%
3.9%
Q4 24
-6.6%
20.1%
Q3 24
-2.8%
-14.4%
Q2 24
2.1%
37.7%
Q1 24
-5.5%
1.5%
EPS (diluted)
CLOV
CLOV
MSGE
MSGE
Q4 25
$1.94
Q3 25
$-0.46
Q2 25
$-0.56
Q1 25
$0.17
Q4 24
$1.56
Q3 24
$-0.40
Q2 24
$1.32
Q1 24
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
MSGE
MSGE
Cash + ST InvestmentsLiquidity on hand
$78.3M
$157.1M
Total DebtLower is stronger
$554.6M
Stockholders' EquityBook value
$308.7M
$36.0M
Total Assets
$541.0M
$1.8B
Debt / EquityLower = less leverage
15.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
MSGE
MSGE
Q4 25
$78.3M
$157.1M
Q3 25
$29.9M
Q2 25
$43.0M
Q1 25
$89.0M
Q4 24
$194.5M
$54.9M
Q3 24
$288.0M
$37.3M
Q2 24
$254.8M
$33.3M
Q1 24
$208.3M
$28.0M
Total Debt
CLOV
CLOV
MSGE
MSGE
Q4 25
$554.6M
Q3 25
$581.7M
Q2 25
$568.8M
Q1 25
$577.4M
Q4 24
$584.7M
Q3 24
$647.0M
Q2 24
$599.2M
Q1 24
$602.5M
Stockholders' Equity
CLOV
CLOV
MSGE
MSGE
Q4 25
$308.7M
$36.0M
Q3 25
$340.9M
$-65.8M
Q2 25
$344.2M
$-13.3M
Q1 25
$336.1M
$9.5M
Q4 24
$341.1M
$10.3M
Q3 24
$342.2M
$-48.7M
Q2 24
$324.9M
$-23.2M
Q1 24
$292.5M
$-94.6M
Total Assets
CLOV
CLOV
MSGE
MSGE
Q4 25
$541.0M
$1.8B
Q3 25
$559.7M
$1.7B
Q2 25
$575.0M
$1.7B
Q1 25
$583.7M
$1.7B
Q4 24
$580.7M
$1.6B
Q3 24
$653.0M
$1.6B
Q2 24
$674.2M
$1.6B
Q1 24
$671.8M
$1.5B
Debt / Equity
CLOV
CLOV
MSGE
MSGE
Q4 25
15.40×
Q3 25
Q2 25
Q1 25
60.61×
Q4 24
56.61×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
MSGE
MSGE
Operating Cash FlowLast quarter
$-66.9M
$164.4M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
1.77×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
MSGE
MSGE
Q4 25
$-66.9M
$164.4M
Q3 25
$12.1M
$19.8M
Q2 25
$5.4M
$-27.0M
Q1 25
$-16.3M
$56.8M
Q4 24
$34.8M
$112.9M
Q3 24
$50.0M
$-27.4M
Q2 24
$44.8M
$212.0K
Q1 24
$25.9M
$5.8M
Free Cash Flow
CLOV
CLOV
MSGE
MSGE
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
MSGE
MSGE
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
MSGE
MSGE
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
MSGE
MSGE
Q4 25
1.77×
Q3 25
Q2 25
Q1 25
7.07×
Q4 24
1.49×
Q3 24
Q2 24
6.04×
0.00×
Q1 24
2.08×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

MSGE
MSGE

Ticketing And Venue License Fee Revenues$263.5M62%
Food Beverage And Merchandise Revenues$64.3M15%
Related Party$43.9M10%
Arena Licensing Fees And Other Leasing Revenue$35.2M8%
Other$15.9M4%

Related Comparisons